pyrimethamine has been researched along with P carinii Pneumonia in 101 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent toxoplasmic encephalitis relapse in patients with the acquired immunodeficiency syndrome (AIDS)." | 9.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 9.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "To evaluate the safety and efficacy of a fixed 25mg pyrimethamine--500mg sulfadoxine combination plus 15mg folinic acid given twice weekly for the prevention of relapses of Pneumocystis carinii pneumonia (PCP) and primary episodes of toxoplasmic encephalitis." | 7.71 | Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. ( Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T, 2001) |
| "The efficacy and safety of 25 mg pyrimethamine plus 500 mg sulfadoxine given twice a week in preventing relapses of AIDS-related toxoplasmic encephalitis was evaluated in an open study." | 7.68 | Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. ( Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H, 1993) |
| "The incidence of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) was analyzed in 83 human immunodeficiency virus (HIV)-infected patients who inhaled aerosolized pentamidine (AP) either for primary prophylaxis (group Ia) or secondary prophylaxis (group IIa) of PCP." | 7.68 | Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. ( Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B, 1992) |
| "We assessed the incidence and determinants of bacteremia, pneumonia, and sinusitis/otitis in HIV-positive people receiving cotrimoxazole (CTX) or dapsone-pyrimethamine (DP) for primary prophylaxis of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) within a randomized clinical trial." | 5.09 | Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. ( Ammassari, A; Antinori, A; Cingolani, A; De Luca, A; Grillo, R; Murri, R; Pallavicini, F; Pezzotti, P, 2001) |
| "To evaluate the efficacy of twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent toxoplasmic encephalitis relapse in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 5.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "In a meta-analysis, we examined the efficacy of aerosolized pentamidine, trimethoprim-sulfamethoxazole, and dapsone or dapsone/pyrimethamine for the prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in patients with HIV infection." | 4.79 | Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. ( Bucher, HC; Griffith, L; Guyatt, GH; Opravil, M, 1997) |
| "The widespread emergence of chloroquine-resistant Plasmodium falciparum led to the formulation of an effective, fixed combination of two antimalarial agents, pyrimethamine and the long-acting sulfonamide sulfadoxine, for prophylaxis and treatment." | 4.77 | Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. ( Hewlett, EL; Pearson, RD, 1987) |
| "To evaluate the safety and efficacy of a fixed 25mg pyrimethamine--500mg sulfadoxine combination plus 15mg folinic acid given twice weekly for the prevention of relapses of Pneumocystis carinii pneumonia (PCP) and primary episodes of toxoplasmic encephalitis." | 3.71 | Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. ( Albrecht, H; Behnsch, M; Bergmann, F; Grobusch, M; Grünewald, T; Padberg, J; Ruf, B; Schürmann, D; Suttorp, N; Vallée, M; Wünsche, T, 2001) |
| "The efficacy and safety of 25 mg pyrimethamine plus 500 mg sulfadoxine given twice a week in preventing relapses of AIDS-related toxoplasmic encephalitis was evaluated in an open study." | 3.68 | Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. ( Bergmann, F; Gottschalk, HJ; Grünewald, T; Pohle, HD; Ruf, B; Schüler-Maué, W; Schürmann, D; Witt, H, 1993) |
| "The incidence of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) was analyzed in 83 human immunodeficiency virus (HIV)-infected patients who inhaled aerosolized pentamidine (AP) either for primary prophylaxis (group Ia) or secondary prophylaxis (group IIa) of PCP." | 3.68 | Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. ( Gottschalk, J; Grünewald, T; Jautzke, G; Köppen, S; Pohle, HD; Ruf, B, 1992) |
| "The combination of pyrimethamine and sulfadoxine (Fansidar) has been reported to cause severe skin reactions including erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis." | 3.67 | Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person. ( Dinan, WA; Pablos-Mendez, A; Palagiano, A; Raviglione, MC; Sabatini, MT, 1988) |
| " The pharmacokinetics of dapsone and pyrimethamine were examined by using a population pharmacokinetic model." | 2.67 | Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia. ( Amantea, MA; Byrne, A; Davey, RT; Falloon, J; Graziani, A; Lavelle, J; Morgan, A; Ogata-Arakaki, D; Ownby, K; Polis, M, 1994) |
| "Although the incidence of Pneumocystis carinii pneumonia (PCP) among adults infected with human immunodeficiency virus (HIV) has declined, no decline in PCP incidence has been observed among HIV-infected children, and PCP remains the most common serious opportunistic infection among both adults and children in the United States." | 2.39 | Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. ( Feinberg, J; Hughes, WT; Navin, TR; Simonds, RJ, 1995) |
| "Although Pneumocystis carinii pneumonia (PCP) can occur in any patient with severe impairment of immunity, there has been a sharp rise in incidence with the spread of human immunodeficiency virus through the USA and Western Europe, where nearly 80% of patients with HIV infection have at least one episode of PCP during their lifetime (Murray et al, 1984)." | 2.38 | Prophylaxis and treatment of Pneumocystis carinii pneumonia. ( Bateman, NT; O'Doherty, MJ, 1991) |
| " Dosage must be adjusted to the results of blood counts." | 2.38 | [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991) |
| "Treatment with trimethoprim-sulfamethoxazole (TMP) should be instituted as early as possible: a serum level of TMP between 5 and 10 micrograms/ml should be attained." | 2.37 | [Pneumocystis carinii infections]. ( Mojon, M, 1985) |
| "To analyse the incidence of Pneumocystis carinii pneumonia after the withdrawal of prophylaxis, in patients with AIDS who were receiving HAART (highly active antiretroviral treatment)." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| "Pneumocystis carinii pneumonia has been the most common life-threatening opportunistic infection in patients with acquired immunodeficiency syndrome." | 1.29 | Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia. ( Glatt, AE, 1994) |
| "Extrapulmonary pneumocystosis is a feature of severe immunosuppression which earlier reports have suggested is limited to patients receiving either no prophylaxis or aerosolised pentamidine." | 1.29 | Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis. ( Carlin, EM; Coker, RJ; Goldin, RD; Harris, JR, 1993) |
| "Patients with cerebral toxoplasmosis have a low risk for subsequently developing P." | 1.28 | Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. ( Chave, JP; Flepp, M; Gabriel, V; Heald, A; Hirschel, B; Malinverni, R; Renold, C; Rüttimann, S; Sugar, A, 1991) |
| "In 33 consecutive AIDS patients with a first episode of Pneumocystis carinii pneumonia (PCP) we evaluated treatment, outcome, recurrence rate and pyrimethamine as chemoprophylaxis in a 1-year follow-up." | 1.28 | Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis. ( Bergdahl, S; Julander, I; Lidman, C; Lundbergh, P; Ortqvist, A, 1989) |
| "Pneumocystis carinii pneumonia is an important infection in patients infected with the human immunodeficiency virus." | 1.28 | Experience with pneumocystis carinii pneumonia in patients with AIDS. ( Davis, R; Ellis-Pegler, RB; Ingram, RJ, 1989) |
| "Infantile pneumocystosis leading to IPCP can be completely prevented by proper feeding and care of the patient or prophylactic drug therapy with sulfadoxine-pyrimethamine." | 1.26 | Therapy and prophylaxis of Pneumocystis carinii pneumonia. ( Bandarizadeh, B; Dutz, W; Fakouhi, T; Jennings-Khodadad, E; Kohout, E; Post, C, 1976) |
| "There are two types of Pneumocystis carinii pneumonia." | 1.26 | [Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)]. ( Ivády, G, 1976) |
| "Pneumocystis carinii pneumonia was suspected in 52 patients who underwent lung biopsy for diagnosis of diffuse pulmonary infiltrates." | 1.25 | Pneumocystis carinii pneumonia. Diagnosis by lung biopsy. ( Armstrong, D; Martini, N; Rosen, PP, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 49 (48.51) | 18.7374 |
| 1990's | 47 (46.53) | 18.2507 |
| 2000's | 5 (4.95) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queener, SF | 2 |
| Piper, JR | 1 |
| Johnson, CA | 1 |
| Krauth, CA | 1 |
| Carter, RL | 1 |
| Hosmer, CA | 1 |
| Borotz, SE | 1 |
| Pfefferkorn, ER | 1 |
| Baran, DA | 1 |
| Alwarshetty, MM | 1 |
| Alvi, S | 1 |
| Arroyo, LH | 1 |
| Lubitz, S | 1 |
| Pinney, S | 1 |
| Gass, AL | 1 |
| Zucker, MJ | 1 |
| Reusser, P | 1 |
| Gottlieb, MS | 1 |
| Knight, S | 1 |
| Mitsuyasu, R | 1 |
| Weisman, J | 1 |
| Roth, M | 1 |
| Young, LS | 1 |
| von Sonnenburg, F | 1 |
| Prüfer, L | 1 |
| Hughes, WT | 4 |
| Podzamczer, D | 4 |
| Miró, JM | 3 |
| Bolao, F | 2 |
| Gatell, JM | 4 |
| Cosín, J | 1 |
| Sirera, G | 2 |
| Domingo, P | 1 |
| Laguna, F | 1 |
| Santamaría, J | 1 |
| Verdejo, J | 1 |
| Salazar, A | 1 |
| Jiménez, J | 2 |
| Consiglio, E | 1 |
| Santín, M | 3 |
| Casanova, A | 2 |
| Rufí, G | 1 |
| Gudiol, F | 2 |
| Opravil, M | 5 |
| Pechère, M | 2 |
| Lazzarin, A | 2 |
| Heald, A | 3 |
| Rüttimann, S | 3 |
| Iten, A | 2 |
| Furrer, H | 1 |
| Oertle, D | 2 |
| Praz, G | 2 |
| Vuitton, DA | 1 |
| Hirschel, B | 2 |
| von Overbeck, J | 1 |
| Bessesen, MT | 1 |
| Miller, LA | 1 |
| Cohn, DL | 1 |
| Bartlett, S | 1 |
| Ellison, RT | 1 |
| Jurado, R | 1 |
| Garcia-Herola, A | 1 |
| Garcia-Lazaro, M | 1 |
| Kindelan, JM | 1 |
| Villanueva, JL | 1 |
| Torre-Cisneros, J | 2 |
| Falloon, J | 1 |
| Lavelle, J | 1 |
| Ogata-Arakaki, D | 1 |
| Byrne, A | 1 |
| Graziani, A | 1 |
| Morgan, A | 1 |
| Amantea, MA | 1 |
| Ownby, K | 1 |
| Polis, M | 1 |
| Davey, RT | 1 |
| Tocchetti, A | 1 |
| Tambini, R | 1 |
| Allegro, A | 1 |
| Longoni, E | 1 |
| Rinaldi, E | 1 |
| Joos, B | 1 |
| Lüthy, R | 2 |
| Jacobson, MA | 1 |
| Besch, CL | 1 |
| Child, C | 1 |
| Hafner, R | 1 |
| Matts, JP | 1 |
| Muth, K | 1 |
| Wentworth, DN | 1 |
| Neaton, JD | 1 |
| Abrams, D | 1 |
| Rimland, D | 1 |
| Glatt, AE | 1 |
| Ruf, B | 4 |
| Schürmann, D | 3 |
| Bergmann, F | 3 |
| Schüler-Maué, W | 1 |
| Grünewald, T | 4 |
| Gottschalk, HJ | 1 |
| Witt, H | 1 |
| Pohle, HD | 2 |
| Mallolas, J | 3 |
| Zamora, L | 3 |
| Vernet, E | 1 |
| Valls, ME | 1 |
| Soriano, E | 2 |
| SanMiguel, JG | 1 |
| Martos, A | 1 |
| Ferrer, I | 1 |
| Girard, PM | 2 |
| Landman, R | 1 |
| Gaudebout, C | 2 |
| Olivares, R | 1 |
| Saimot, AG | 1 |
| Jelazko, P | 1 |
| Certain, A | 1 |
| Boué, F | 1 |
| Bouvet, E | 1 |
| Gudiol, GR | 1 |
| Carlin, EM | 1 |
| Coker, RJ | 2 |
| Goldin, RD | 1 |
| Harris, JR | 2 |
| Keusch, G | 1 |
| Simonds, RJ | 1 |
| Feinberg, J | 1 |
| Navin, TR | 2 |
| Antinori, A | 4 |
| Murri, R | 4 |
| Ammassari, A | 2 |
| De Luca, A | 4 |
| Linzalone, A | 1 |
| Cingolani, A | 2 |
| Damiano, F | 1 |
| Maiuro, G | 1 |
| Vecchiet, J | 1 |
| Scoppettuolo, G | 1 |
| Tamburrini, E | 2 |
| Mencarini, P | 1 |
| Visconti, E | 1 |
| Zolfo, M | 1 |
| Siracusano, A | 1 |
| Ortona, E | 1 |
| Bucher, HC | 1 |
| Griffith, L | 1 |
| Guyatt, GH | 1 |
| Teira, R | 1 |
| Virosta, M | 1 |
| Muñoz, J | 1 |
| Zubero, Z | 1 |
| Santamaría, JM | 1 |
| Fishman, JA | 1 |
| Payen, MC | 1 |
| De Wit, S | 1 |
| Sommereijns, B | 1 |
| Clumeck, N | 1 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| Arendt, G | 1 |
| von Giesen, HJ | 1 |
| Hefter, H | 1 |
| Neuen-Jacob, E | 1 |
| Roick, H | 1 |
| Jablonowski, H | 1 |
| De la Mata, M | 1 |
| Pozo, JC | 1 |
| Serrano, P | 1 |
| Briceño, J | 1 |
| Solórzano, G | 1 |
| Miño, G | 1 |
| Pera, C | 1 |
| Sánchez-Guijo, P | 1 |
| Albrecht, H | 2 |
| Padberg, J | 2 |
| Behnsch, M | 1 |
| Grobusch, M | 2 |
| Vallée, M | 2 |
| Wünsche, T | 2 |
| Suttorp, N | 2 |
| Asencio Marchante, R | 1 |
| Lissen Otero, E | 1 |
| Dorrell, L | 1 |
| McCallum, AK | 1 |
| Snow, MH | 1 |
| Ong, EL | 1 |
| Cheng, B | 1 |
| Walker, MJ | 1 |
| Pezzotti, P | 1 |
| Pallavicini, F | 1 |
| Grillo, R | 1 |
| Schürmann, M | 1 |
| Danilevicius, Z | 1 |
| Ryning, FW | 1 |
| Mills, J | 1 |
| Hallett, JJ | 1 |
| Fickenscher, LG | 1 |
| Ablin, AR | 1 |
| Dutz, W | 3 |
| Post, C | 2 |
| Jennings-Khodadad, E | 1 |
| Fakouhi, T | 2 |
| Kohout, E | 1 |
| Bandarizadeh, B | 2 |
| Rosen, PP | 1 |
| Martini, N | 1 |
| Armstrong, D | 1 |
| Sizoo, W | 1 |
| Wolvius, GG | 1 |
| Ivády, G | 1 |
| Young, RC | 1 |
| DeVita, VT | 2 |
| Iváldy, G | 1 |
| Páldy, L | 1 |
| Whisnant, JK | 1 |
| Buckley, RH | 1 |
| Helmer, RE | 1 |
| Ortona, L | 1 |
| Köppen, S | 1 |
| Jautzke, G | 1 |
| Gottschalk, J | 1 |
| Nieman, R | 1 |
| McBride, M | 1 |
| Mitchell, DM | 1 |
| Weber, JN | 1 |
| Hardy, WD | 2 |
| O'Doherty, MJ | 1 |
| Bateman, NT | 1 |
| Niyongabo, T | 1 |
| Leport, C | 1 |
| Vildé, JL | 1 |
| Vinogradov, NA | 1 |
| Clotet, B | 1 |
| Romeu, J | 1 |
| Gimeno, JM | 1 |
| Jou, A | 1 |
| Condom, MJ | 1 |
| Tor, J | 1 |
| Foz, M | 1 |
| Soma, K | 1 |
| Flepp, M | 1 |
| Chave, JP | 1 |
| Malinverni, R | 1 |
| Gabriel, V | 1 |
| Renold, C | 1 |
| Sugar, A | 1 |
| Takada, S | 1 |
| Lepretre, A | 1 |
| Detruchis, P | 1 |
| Matheron, S | 1 |
| Coulaud, JP | 1 |
| Lidman, C | 1 |
| Ortqvist, A | 1 |
| Lundbergh, P | 1 |
| Julander, I | 1 |
| Bergdahl, S | 1 |
| Gilman, TM | 1 |
| Boylen, CT | 1 |
| Sattler, FR | 1 |
| Ingram, RJ | 1 |
| Davis, R | 1 |
| Ellis-Pegler, RB | 1 |
| Miller, KD | 1 |
| Satriale, RF | 1 |
| Lobel, HO | 1 |
| Kovacs, JA | 1 |
| Masur, H | 1 |
| Frissen, PH | 1 |
| Stronkhorst, A | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| Danner, SA | 1 |
| Walzer, PD | 1 |
| Kim, CK | 1 |
| Foy, JM | 1 |
| Linke, MJ | 1 |
| Cushion, MT | 1 |
| Raviglione, MC | 1 |
| Dinan, WA | 1 |
| Pablos-Mendez, A | 1 |
| Palagiano, A | 1 |
| Sabatini, MT | 1 |
| Fischl, MA | 1 |
| Dickinson, GM | 1 |
| Bath, PM | 1 |
| Lillicrap, DA | 1 |
| Winter, M | 1 |
| Pearson, RD | 1 |
| Hewlett, EL | 1 |
| Szabados, A | 1 |
| Schierz, G | 1 |
| Deinhardt, F | 1 |
| Mojon, M | 1 |
| Catterall, JR | 1 |
| Potasman, I | 1 |
| Remington, JS | 2 |
| Panov, A | 1 |
| Kim, HK | 1 |
| Price, RA | 1 |
| Miller, C | 1 |
| Weiss, EB | 1 |
| Katz, S | 1 |
| Tyras, DH | 1 |
| Campbell, W | 1 |
| Corley, C | 1 |
| Hatcher, CR | 1 |
| Robbins, JB | 1 |
| Boda, D | 1 |
| Anderson, SE | 1 |
| Chobot-Maciejewska, H | 1 |
| Kosicka, M | 1 |
| Januszkiewicz, A | 1 |
| Kohout, EE | 1 |
| Frenkel, JK | 1 |
| Good, JT | 1 |
| Shultz, JA | 1 |
| Kordyasz, E | 1 |
| Ratajczak-Majewska, C | 1 |
| Szmigiel, C | 1 |
| Stopyrowa, J | 1 |
| Baniowski, A | 1 |
| Kirby, HB | 1 |
| Kenamore, B | 1 |
| Guckian, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection[NCT00000666] | 600 participants | Interventional | Completed | ||||
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)[NCT04844099] | Phase 3 | 723 participants (Actual) | Interventional | 2021-04-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for pyrimethamine and P carinii Pneumonia
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infectio | 1995 |
[Progress in immunodiagnosis and chemotherapy of protozoan infections].
Topics: Amebiasis; Animals; Antibodies; Babesiosis; Chloroquine; Drug Resistance, Microbial; Giardiasis; Hum | 1983 |
Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; | 1995 |
Recent advances in the prevention of pneumocystis carinii pneumonia.
Topics: Aerosols; Child; Dapsone; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Trimethoprim, | 1996 |
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal | 1997 |
Prevention of infection due to Pneumocystis carinii.
Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Fungal Vaccine | 1998 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Prophylaxis and treatment of Pneumocystis carinii pneumonia.
Topics: Antimalarials; CD4-Positive T-Lymphocytes; Clinical Protocols; Dapsone; Drug Combinations; HIV Infec | 1991 |
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum | 1991 |
[Diagnosis and treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Diagnosis, Differential; Humans; Pneumonia, Pneumoc | 1991 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combin | 1989 |
Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Therapy, Combination; Humans; Pneumonia, Pneumocys | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneum | 1988 |
Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Topics: Acquired Immunodeficiency Syndrome; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria | 1987 |
[Pneumocystis carinii pneumonia].
Topics: Adult; Animals; Antibodies; Antimalarials; Child; Drug Combinations; Drug Therapy, Combination; Huma | 1985 |
[Pneumocystis carinii infections].
Topics: Animals; Child; Drug Combinations; France; History, 20th Century; Humans; Pentamidine; Pneumonia, Pn | 1985 |
Pneumocystis carinii pneumonia.
Topics: Adolescent; Adult; Apicomplexa; Child; Child, Preschool; Female; Humans; Immunoglobulins; Immunologi | 1970 |
24 trials available for pyrimethamine and P carinii Pneumonia
| Article | Year |
|---|---|
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Dapsone; Drug Administration Schedule; Drug Ther | 1995 |
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Animals; Dapsone; Drug Adm | 1995 |
Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Administration, Inhalation; Adolescent; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, | 1995 |
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Biological Availability; Chromatography, High Pressure | 1994 |
Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Female; Follow-Up | 1994 |
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; HIV Infections; Humans; M | 1994 |
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Drug Therapy, Co | 1993 |
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Topics: Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Dapsone; Drug Combinations; Ence | 1993 |
Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Administration Schedule; Drug Therapy, C | 1993 |
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infe | 1995 |
A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti | 1997 |
Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Humans; Liver Transplantation; Male; | 1999 |
Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial.
Topics: Adult; Animals; Anti-Infective Agents; Bacterial Infections; Dapsone; Encephalitis; Female; HIV Infe | 2001 |
Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Antiretroviral T | 2002 |
Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine.
Topics: Administration, Oral; Adult; Aged; Amidines; Child; Drug Therapy, Combination; Female; Humans; Injec | 1976 |
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
Topics: Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pneumonia, Pneumocystis; Pyrimethamine; | 1992 |
Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Topics: Adult; CD4-Positive T-Lymphocytes; Dapsone; Drug Administration Schedule; Female; Humans; Leukocyte | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Follow-Up Studies; Humans; Pentamidine; Pneumonia, Pneu | 1991 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug C | 1985 |
[Results of treatment of pneumocystic pneumonia with pentamidin isethionate and daraprim].
Topics: Amidines; Clinical Trials as Topic; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine | 1968 |
Prophylaxis of epidemic infantile pneumocystosis with a 20:1 sulfadoxine+pyrimethamine combination.
Topics: Age Factors; Autopsy; Biopsy; Bone Marrow; Complement Fixation Tests; Female; Folic Acid; Humans; In | 1971 |
60 other studies available for pyrimethamine and P carinii Pneumonia
| Article | Year |
|---|---|
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
Topics: Animals; Anti-Infective Agents; Folic Acid Antagonists; Opportunistic Infections; Pneumocystis; Pneu | 1996 |
Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers.
Topics: Adult; Anti-Infective Agents; Antiprotozoal Agents; Female; Follow-Up Studies; Graft Rejection; Hear | 2006 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Middle Aged; | 1980 |
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1984 |
Pneumocystis carinii pneumonitis.
Topics: Animals; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazin | 1981 |
Pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Female; Humans; Male; Middle Aged; Pne | 1994 |
Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Adult; Aged; Dapsone; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Phenotyp | 1994 |
Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clindamycin; Dapso | 1994 |
Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Administration Schedule; D | 1993 |
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Humans; Liver Dise | 1993 |
Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Com | 1993 |
Pyrimethamine inhibits renal secretion of creatinine.
Topics: Adult; Creatinine; Dapsone; Drug Administration Schedule; Drug Interactions; Female; Humans; Kidney; | 1993 |
Prophylaxis of pneumocystis pneumonia and toxoplasmosis.
Topics: Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Humans; Pneumonia, Pneumocystis; Pyrimeth | 1996 |
Imbalance between Pneumocystis carinii cysts and trophozoites in bronchoalveolar lavage fluid from patients with pneumocystosis receiving prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Bronchoalveo | 1996 |
The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
Topics: Adult; Anti-Infective Agents; Female; Humans; Incidence; Male; Pneumocystis; Pneumonia, Pneumocystis | 1997 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
Long-term course and outcome in AIDS patients with cerebral toxoplasmosis.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiprot | 1999 |
Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cohort Studies; Drug Comb | 2001 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal A | 2001 |
Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents | 1995 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasi | 1995 |
Editorial: A call to recognize PCP.
Topics: Alkanesulfonates; Amidines; Biopsy; Child; Developing Countries; Drug Therapy, Combination; Humans; | 1975 |
Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host.
Topics: Adolescent; Adult; Animals; Cats; Child; Child, Preschool; Cytomegalovirus Infections; Female; Human | 1979 |
Pneumocystis carinii pneumonia in children.
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadi | 1977 |
Therapy and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Amidines; Aminosalicylic Acid; Animals; Complement Fixation Tests; Drug Therapy, Combination; Humans | 1976 |
Pneumocystis carinii pneumonia. Diagnosis by lung biopsy.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; M | 1975 |
[Pneumocystis pneumonia as a complication in cytostatic therapy].
Topics: Adolescent; Antineoplastic Agents; Female; Humans; Male; Neoplasms; Pentamidine; Pneumonia, Pneumocy | 1976 |
[Current aspects of differentiation and treatment of pneumocystis carinii pneumonia (author's transl)].
Topics: Age Factors; Dihydroergotoxine; Humans; Immunologic Deficiency Syndromes; Infant; Pentamidine; Pneum | 1976 |
Treatment of Pneumocystis carinii pneumonia in infancy.
Topics: Dihydroergotoxine; Drug Therapy, Combination; Female; Folic Acid; Humans; Infant; Infant, Newborn; I | 1976 |
Successful pyrimethamine-sulfadiazine therapy of pneumocystis pneumonia in infants with X-linked immunodeficiency with hyper-IgM.
Topics: Dysgammaglobulinemia; Genetic Linkage; Humans; Immunoglobulin M; Infant; Male; Pneumonia, Pneumocyst | 1976 |
Hazard of folinic acid with pyrimethamine and sulfadiazine.
Topics: Amidines; Drug Combinations; Drug Interactions; Humans; Leucovorin; Leukemia; Pentamidine; Pneumonia | 1975 |
Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.
Topics: Adult; Aerosols; Aged; CD4-Positive T-Lymphocytes; Drug Combinations; Encephalitis; Female; HIV Infe | 1992 |
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Dapsone; Drug Administration Schedule; Drug Ther | 1991 |
[Diagnosis and therapy of parasitic lung diseases].
Topics: Humans; Lung Diseases, Parasitic; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; | 1991 |
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Clindamycin; Cohort Studies; Drug Therapy, Combinat | 1991 |
[Drugs used against protozoan infections in man].
Topics: Amebiasis; Aminoquinolines; Antiprotozoal Agents; Humans; Malaria; Metronidazole; Pneumonia, Pneumoc | 1990 |
Failure of pyrimethamine-clindamycin combination for prophylaxis of Pneumocystis carinii pneumonia.
Topics: Clindamycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Pneum | 1989 |
Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Dapsone; Drug Evaluation; Drug Therapy, Combination | 1989 |
Experience with pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bronchoscopy; Drug Combinations; Follow-Up Studies; Homos | 1989 |
Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1985 |
Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middl | 1988 |
Fansidar and Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Combinations; Humans; Male; Pneumonia, Pneumocystis; | 1988 |
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Topics: Animals; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Male | 1988 |
Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
Topics: Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; Homosexuality; Humans; Male; Middl | 1988 |
Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Male; Middle Aged; Pneumonia, Pneumoc | 1988 |
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Humans; Pneumonia, Pneumocystis; Pyrimethamin | 1986 |
Fansidar--a treatment for AIDS-related pneumocystis?
Topics: Acquired Immunodeficiency Syndrome; Antimalarials; Drug Combinations; Humans; Pneumonia, Pneumocysti | 1987 |
[Clinical aspects and treatment of pneumocystic pneumonia].
Topics: gamma-Globulins; Humans; Infant; Pneumonia, Pneumocystis; Pyrimethamine; Quinine; Sulfonamides | 1971 |
Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis.
Topics: Amidines; Animals; Cortisone; Immunization; Male; Pneumonia, Pneumocystis; Pyrimethamine; Rats; Sulf | 1973 |
Editorial: In pursuit of Pneumocystis carinii.
Topics: Biopsy; Bis-Trimethylammonium Compounds; Bronchoscopy; Diagnosis, Differential; Humans; Mycobacteriu | 1973 |
Pneumocystis carinii pneumonia.
Topics: Adult; Alkanesulfonates; Amidines; Biopsy; Biopsy, Needle; Bronchoscopy; Child; Drug Therapy, Combin | 1974 |
The role of early open lung biopsy in the diagnosis and treatment of Pneumocystis carinii pneumonia.
Topics: Adult; Aged; Alkanesulfonates; Amidines; Biopsy; Female; Histiocytes; Humans; Lung; Male; Middle Age | 1974 |
An increasing awareness of pneumocystis carinii pneumonitis.
Topics: Amidines; Antiprotozoal Agents; Humans; Phenols; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazin | 1972 |
The importance of insterstitial (plasma cell) pneumonia and its correlation with immunodeficiency.
Topics: Cross Infection; Drug Therapy, Combination; Female; Humans; Immunologic Deficiency Syndromes; Infant | 1972 |
Diagnosis and treatment of pneumocystosis and toxoplasmosis in the immunosuppressed host.
Topics: Anti-Bacterial Agents; Cerebrospinal Fluid; Drug Combinations; Fluorescent Antibody Technique; Hemag | 1973 |
Latent Pneumocystis infection of rats, relapse, and chemotherapy.
Topics: Aminopterin; Animals; Antiprotozoal Agents; Chlorambucil; Chlortetracycline; Cortisone; Cricetinae; | 1966 |
[Successful treatment of infants with pneumonia pneumocystica with daraprim].
Topics: Female; Humans; Infant; Male; Pneumonia, Pneumocystis; Pyrimethamine | 1966 |
[Clinical picture and treatment of pneumocystis carinii pneumonia in infants].
Topics: Anti-Bacterial Agents; Humans; Infant; Infant, Newborn; Oxygen Inhalation Therapy; Pneumonia, Pneumo | 1971 |
Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine.
Topics: Adult; Follow-Up Studies; Humans; Leukemia, Lymphoid; Lupus Erythematosus, Systemic; Lymphoma, Non-H | 1971 |